relapse leukemia
Showing 1 - 11 of 11
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Indian Children With Acute Lymphoblastic Leukemia
Not yet recruiting
- ALL, Childhood
- +7 more
-
New Delhi, India
- +1 more
Aug 22, 2022
Relapsed or Refractory Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
Cona, Ferrara, Italy
- +26 more
Jan 3, 2022
Relapse Leukemia, Refractory Leukemia Trial in Shenzhen (Allogeneic CD19 CAR-T cells)
Recruiting
- Relapse Leukemia
- Refractory Leukemia
- Allogeneic CD19 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Dec 7, 2021
Acute Myeloid Leukemia, Relapse Leukemia, Refractory Acute Myeloid Leukemia Trial in Beijing (chimeric antigen receptor T cell)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- chimeric antigen receptor T cell
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Sep 14, 2021
Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)
Unknown status
- Acute Myeloid Leukemia
- Relapse Leukemia
- Cladribine
- +3 more
-
Guangzhou, Guangdong, ChinaLiang Wang
Aug 18, 2019
Stem Cell Transplant Complications, Relapse Leukemia, Refractory Leukemia Trial in Beijing (Decitabine, mBU/CY and ATG, mBU/CY)
Recruiting
- Stem Cell Transplant Complications
- +2 more
- Decitabine
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
May 27, 2019
Relapse Leukemia, Allogeneic Stem Cell Transplantation, Immune Evasion, Tumor Trial (blood sample, bone marrow sample)
Unknown status
- Relapse Leukemia
- +2 more
- blood sample
- bone marrow sample
- (no location specified)
May 24, 2019
Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL Trial in Montreal (GLIDE)
Unknown status
- Hematologic Cancer
- +8 more
- GLIDE
-
Montreal, Quebec, CanadaCIUSSS d l'Est-de-l'Île-de-Montréal
Dec 4, 2017
HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched
Completed
- Relapse Leukemia
- the first donor's stem cell
- the second donor's stem cell
-
Beijing, Beijing, ChinaAffiliated Hospital of Academy of Military Medical Sciences
Jul 12, 2016